Achieve Life Sciences Inc (id:5536 ACHV)
3.79 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 9:13:17 AM)
Exchange closed, opens in 16 minutes
2.13 USD (2.13%)
-9.11 USD (-9.11%)
-9.76 USD (-9.76%)
-18.49 USD (-18.49%)
-9.76 USD (-9.76%)
-65.55 USD (-65.55%)
-99.92 USD (-99.92%)
-100.00 USD (-100.00%)
About Achieve Life Sciences Inc
Market Capitalization 134.12M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
| Headquarters (address) |
1040 West Georgia Street Vancouver V6E 4H1 BC Canada |
| Phone | 604-210-2217 |
| Website | https://www.achievelifesciences.com |
| Employees | 22 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | ACHV |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.60 - 5.58 |
| Market Capitalization | 134.12M |
| P/E trailing | -2.53 |
| P/E forward | -3.39 |
| Price/Book | 4.28 |
| Beta | 1.58 |
| EPS | -1.12 |
| EPS Canada (ID:82, base:720) | 2.18 |